Last update 13 Nov 2024

Timtraxanib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
AVI 3207
Target
VEGFR2
Mechanism
VEGFR2 antagonists(Vascular endothelial growth factor receptor 2 antagonists)
Therapeutic Areas
Congenital DisordersEye Diseases
Active Indication
Retinal Degeneration
Inactive Indication-
Originator Organization
Avixgen, Inc.Avixgen, Inc.
Active Organization
Avixgen, Inc.Avixgen, Inc.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC28H43N7O9
InChIKeyCTHOVYCXWNPTSN-CMOCDZPBSA-N
CAS Registry2412172-33-7

Related

1
Clinical Trials associated with Timtraxanib
KCT0004887 / RecruitingPhase 1
Phase 1 study to determine the maximum tolerated dose and to assess the safety, pharmacokinetics, and efficacy of AVI-3207 Inj. in patients with neovascular age-related macular degeneration
100 Clinical Results associated with Timtraxanib
Login to view more data
100 Translational Medicine associated with Timtraxanib
Login to view more data
100 Patents (Medical) associated with Timtraxanib
Login to view more data
100 Deals associated with Timtraxanib
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Retinal DegenerationPhase 1
KR
Avixgen, Inc.Avixgen, Inc.
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free